http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106660950-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_872dd7cd609eb2a937dcfd303d521798
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
filingDate 2015-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ab288034e546d549f9d9ce251fe9839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b98f8fdf1778eebde34be0b42a7c011
publicationDate 2017-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106660950-A
titleOfInvention Use of CXCR2 antagonists for preventing and/or treating chemotherapy-induced peripheral neuropathy (CIPN)
abstract The present invention relates to the use of CXCR2 antagonists for preventing and/or treating chemotherapy-induced peripheral neuropathy (CIPN).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108463219-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021004531-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107779436-A
priorityDate 2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107027306-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2388006-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008039876-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010256157-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466753594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118540538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432002094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164168883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467250089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465094346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163517464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467240866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467577224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118540521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467577274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467237100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467200190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466040392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432008417

Total number of triples: 92.